Foley vs Propess for Induction of Labor in Women With Term PROM : Mode of Delivery, Maternal and Fetal Outcomes

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT04565340
Collaborator
(none)
188
1
5
37.4

Study Details

Study Description

Brief Summary

Premature rupture of membranes at term is a rupture that occurs at term (>37SA) before the start of labor. It complicates 5 to 10% of pregnancies and 6 to 22% of term pregnancies.

Althought some studies support efficacy of the Foley catheter for cervical ripening at term in induction of labor with intact membranes, it has not been well studied in women with premature rupture of membranes at term.

The aim of this retrospective study at the Montpellier University Hospital is to evaluate the effect of the Foley catheter compared to Propess in women with premature rupture of membranes at term, on the induction of labor and the maternal and fetal complications.

Condition or Disease Intervention/Treatment Phase
  • Other: Mode of delivery, maternal and neonatal outcomes/complications

Study Design

Study Type:
Observational
Actual Enrollment :
188 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Foley Catheter Versus Prostaglandin E2 (Propess) Inserts for Induction of Labor in Women With Term Premature Rupture Of Membranes : Mode of Delivery and Maternal and Fetal Outcomes
Actual Study Start Date :
Mar 1, 2020
Actual Primary Completion Date :
Mar 30, 2020
Actual Study Completion Date :
Aug 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Induction of labor with Foley catheter

Induction of labor with Foley catheter

Induction of labor with Propess

Induction of labor with Propess

Other: Mode of delivery, maternal and neonatal outcomes/complications
Mode of delivery, maternal and neonatal outcomes/complications

Outcome Measures

Primary Outcome Measures

  1. mode of delivery (vaginal delivery or cesarean) [1 day]

    mode of delivery (vaginal delivery or cesarean)

Secondary Outcome Measures

  1. maternal and fetal outcomes [1 day]

    looking for maternal complications (endometritis, chorioamniotitis, transfusion, post-partum hemorrhage) and neonatal complications (sepsis, apgar<7 at 5minutes, pH <7,15, neonatal intensive care unit)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Singleton Pregnancy >37 weeks of gestation

  • Premature Rupture Of Membranes

  • Cephalic presentation

  • Unfavorable cervix (BISHOP <7)

  • No contraindication of induction methods

Exclusion criteria:
  • Multiple gestation

  • PROM with spontaneous labor

  • Induction of labor with both methods

  • Previous cesarean section

  • Unexplained metrorrhagia / Placenta praaevia

  • Suspected intraamniotic infection

  • Herpes simplex virus

  • Human immunodeficiency virus

  • Any contraindication to vaginal delivery

  • Latex allergy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uhmontpellier Montpellier France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Study Director: Florent FUCHS, PUPH, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04565340
Other Study ID Numbers:
  • RECHMPL20_0143
First Posted:
Sep 25, 2020
Last Update Posted:
Sep 25, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 25, 2020